Navigation Links
PhUSE Annual Conference to focus on Patient Centricity
Date:3/14/2013

Brussels, Belgium (PRWEB) March 14, 2013

PhUSE presents the 2013 Annual PhUSE conference. The conference, which will take place in Brussels, Belgium, will turn the spotlight onto ‘Patient Centricity’ in the pharmaceutical world. The conference will address the relationship between the data that drives clinical research and the patients to whom the industry seeks to provide novel therapies, putting patients at the heart of the discussion.

PhUSE is pleased to announce that the keynote speaker at the Annual PhUSE conference will be Doctor Ben Goldacre, science journalist and author of “Bad Pharma.”

"PhUSE has a rich history of excellent keynote presenters and securing Dr. Ben Goldacre just adds to the impressive list of industry influencers. His mix of journalistic skills together with a deep understanding of medicine, the industry and clinical data will give an insight into the challenges that we face as we come to terms with Patent Centricity" says Stephen Bamford, Events Director for PhUSE and Executive Director and co-founder at Cerafor.

The conference will also include workshops focusing on indications, diseases, and data analysis. Through discussion groups, conference attendees will learn and contribute to a better understanding of how to further improve standardization in therapeutic areas, leading to better outcomes for patients. Specifically, Oncology and Rheumatoid Arthritis will be discussed in Therapeutic Area Discussion Clubs.

PhUSE provides a forum second to none for networking and sharing knowledge with colleagues. Attendees at the annual conference will benefit from over 100 presentations centered around the PhUSE topic streams, with 14 diff
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. PhUSE Co-sponsors the Annual FDA/PhUSE Computational Science Symposium, in Silver Spring Maryland, USA, March 18th-19th 2013
2. Kessler Foundation names Dr. John Whyte recipient of Foundations 2nd Annual DeLisa Award
3. Presidential Recognition Awards presented during the 2012 AIUM Annual Convention
4. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
5. ASCO releases studies from upcoming annual meeting
6. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
7. Mayo Clinic urologists present findings at American Urological Association Annual Meeting
8. University Hospitals Case Medical Center experts present at ASCO Annual Meeting
9. Piramal imaging to present data at Society for Nuclear Medicine Annual Meeting
10. Los Robles Hospital’s Annual Health Fair Attended by Khanna Institute
11. NOVAtime Solutions to be showcased at Booth #1821 in the upcoming Society for Human Resource Management (SHRM) Annual Conference and Exposition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, 2014 ... West Africa is starting to spread faster than ever, the World ... the deadly viral infection were reported in just one week. ... with roughly half of those reported in the past three weeks, ... tops 2,600. WHO has estimated that as many as 20,000 ...
(Date:9/18/2014)... It’s been just a few short weeks ... bunion splint to website visitors, but already the response has ... absolutely delighted. It is perfect and I find it sooo ... THANK YOU FOR LISTENING!!!" Another user compared the original ... used to slip to the end of my toe. Now ...
(Date:9/18/2014)... It is that time of year – time ... again, Evensong Spa at Heidel House Resort ... at a special $50 rate Oct. 20 through Nov. 1. ... & Resorts , is the only Wisconsin destination spa participating ... health and wellness by experiencing affordable spa and wellness treatments. ...
(Date:9/18/2014)... supplements of selenium or vitamin E don,t seem ... men, a new study indicates. Previous animal research ... cataracts. To investigate this further, William Christen, from Brigham ... and his colleagues examined data from a randomized, placebo-controlled ... initially designed to study prevention of prostate cancer. ...
(Date:9/18/2014)... 19, 2014 In 2003, ... Mission (Misión Barrio Adentro), which it hoped ... system (see Section 6.1.3.). In 2009, it ... Autonomous Service of Pharmaceutical Elaborations (Servicio Autónomo ... provides medicines at a cheaper rate than ...
Breaking Medicine News(10 mins):Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:Evensong Spa Celebrates Spa Week with $50 Services 2Health News:Evensong Spa Celebrates Spa Week with $50 Services 3Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4
... By Randy Dotinga HealthDay Reporter , TUESDAY, Sept. ... gel based on the active ingredient of the injectable Botox ... known as crow,s feet -- without the pain of needles. ... toxin, last for about four months, comparable to that produced ...
... HealthDay Reporter , TUESDAY, Sept. 20 (HealthDay News) -- Young adults ... birth much thought, but a new study finds that health problems ... some time. From 18 to 36 years of age, people ... death compared to young adults born at a normal gestational age, ...
... Reporter , TUESDAY, Sept. 20 (HealthDay News) -- Adding ... and teens with obsessive-compulsive disorder, new research shows. ... the Journal of the American Medical Association , ... obsessive-compulsive disorder (OCD). "[If] a child has ...
... against methamphetamine and nicotine have been selected to receive ... The two scientists, Dr. Thomas Kosten, of Baylor ... the University of Connecticut, Storrs, will each receive $500,000 ... according to the National Institute on Drug Abuse (NIDA), ...
... 20 (HealthDay News) -- New research finds that compared to ... diagnosis and boosted the likelihood that high-risk, underserved women who ... But there,s a big catch. Researchers were able to reduce ... -- compared to the usual $3,500 -- thanks to a ...
... of Health (NIH) has awarded nearly $2 million to ... University to develop a new class of therapeutics for ... five-year project focuses on developing biomaterials capable of capturing ... to wound sites to enhance tissue regeneration in adults. ...
Cached Medicine News:Health News:Anti-Wrinkle Gel Might Work Like Botox Without Needles 2Health News:Anti-Wrinkle Gel Might Work Like Botox Without Needles 3Health News:Problems From Preterm Birth May Return in Adulthood 2Health News:Problems From Preterm Birth May Return in Adulthood 3Health News:Adding Psychotherapy to Meds Helps Kids With OCD 2Health News:NIDA Avant-Garde-Medications Development Award winners announced 2Health News:MRI Can Spot Breast Cancer in High-Risk Women: Study 2Health News:Transformative NIH grant will support development of tissue regeneration therapeutics 2Health News:Transformative NIH grant will support development of tissue regeneration therapeutics 3
(Date:9/18/2014)... 2014  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of RNA viruses, today announced a research collaboration ... animal testing of the Company,s lead compound, SB ... Pathogens," against which currently there are no effective ... Bank,s proprietary Small Molecule Nucleic Acid Hybrid ...
(Date:9/18/2014)... 18, 2014 /CNW/ - A new expert panel report, ... , released today by the Council of Canadian ... medicines for children. Each year about half of ... least one prescription drug. Much of this prescribing is ... use), creating potential health risks. Children have ...
(Date:9/18/2014)... , Sept. 18, 2014   Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced the first presentation ... AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of Collagenase Optimizing ... study evaluated collagenase clostridium histolyticum (CCH) for the ... same hand. In addition, the study examined expanded ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7
... Incorporated,s (Nasdaq: VPHM ) first quarter financial results ... 28, 2011 before the open of the U.S. financial markets. ... live audio webcast at 9:00 a.m. Eastern Time on the ... the 2011 first quarter financial results and other business. ...
... LLC, through its website lawsuitssettlementfunding.com announced today ... in need of lawsuit cash advances ... leader; however they are striving to set themselves apart ... that they have ramped up their operations involving Avandia ...
Cached Medicine Technology:ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011 2Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2
Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
Substrate Plasma for Factor VIII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VIII has been removed by selective immuno-adsorption....
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Colorimetric Assay of Plasminogen Activity by STA© Analyzers....
Medicine Products: